[HTML][HTML] Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative …
GYH Lip, A Keshishian, A Kang, X Luo, N Atreja… - Journal of Thrombosis …, 2022 - Springer
Introduction There are a paucity of real-world data examining effectiveness and safety of non-
vitamin K antagonist oral anticoagulants (NOACs) and warfarin in nonvalvular atrial …
vitamin K antagonist oral anticoagulants (NOACs) and warfarin in nonvalvular atrial …
[HTML][HTML] Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative …
GYH Lip, A Keshishian, A Kang, X Luo… - … of Thrombosis and …, 2022 - ncbi.nlm.nih.gov
Methods This retrospective analysis included data from 5 insurance claims databases and
included NVAF patients prescribed OACs with prior bleeding. One-to-one propensity score …
included NVAF patients prescribed OACs with prior bleeding. One-to-one propensity score …
Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims …
GYH Lip, A Keshishian, A Kang, X Luo… - … of Thrombosis and …, 2022 - europepmc.org
Methods This retrospective analysis included data from 5 insurance claims databases and
included NVAF patients prescribed OACs with prior bleeding. One-to-one propensity score …
included NVAF patients prescribed OACs with prior bleeding. One-to-one propensity score …
Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims …
GYH Lip, A Keshishian, A Kang, X Luo… - Journal of Thrombosis …, 2022 - vbn.aau.dk
INTRODUCTION: There are a paucity of real-world data examining effectiveness and safety
of non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in nonvalvular atrial …
of non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in nonvalvular atrial …
Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims …
GYH Lip, A Keshishian, A Kang… - … of thrombosis and …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction There are a paucity of real-world data examining effectiveness and safety of non-
vitamin K antagonist oral anticoagulants (NOACs) and warfarin in nonvalvular atrial …
vitamin K antagonist oral anticoagulants (NOACs) and warfarin in nonvalvular atrial …
Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims …
GYH Lip, A Keshishian, A Kang… - JOURNAL OF …, 2022 - livrepository.liverpool.ac.uk
Introduction There are a paucity of real-world data examining effectiveness and safety of non-
vitamin K antagonist oral anticoagulants (NOACs) and warfarin in nonvalvular atrial …
vitamin K antagonist oral anticoagulants (NOACs) and warfarin in nonvalvular atrial …
Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims …
GYH Lip, A Keshishian, A Kang, X Luo… - … of Thrombosis and …, 2022 - search.proquest.com
Methods This retrospective analysis included data from 5 insurance claims databases and
included NVAF patients prescribed OACs with prior bleeding. One-to-one propensity score …
included NVAF patients prescribed OACs with prior bleeding. One-to-one propensity score …
Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims …
GYH Lip, AV Keshishian, A Kang, X Luo, N Atreja… - 2022 - academicworks.cuny.edu
Methods This retrospective analysis included data from 5 insurance claims databases and
included NVAF patients prescribed OACs with prior bleeding. One-to-one propensity score …
included NVAF patients prescribed OACs with prior bleeding. One-to-one propensity score …
[引用][C] Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative …
GYH Lip, A Keshishian, A Kang… - … of Thrombosis and …, 2022 - espace.library.uq.edu.au
Introduction: There are a paucity of real-world data examining effectiveness and safety of
non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in nonvalvular atrial …
non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in nonvalvular atrial …
[PDF][PDF] Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative …
GYH Lip, AV Keshishian, A Kang, X Luo, N Atreja - academicworks.cuny.edu
Introduction There are a paucity of real-world data examining effectiveness and safety of non-
vitamin K antagonist oral anticoagulants (NOACs) and warfarin in nonvalvular atrial …
vitamin K antagonist oral anticoagulants (NOACs) and warfarin in nonvalvular atrial …